The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Alternative Translation of the Proto-oncogene c-mycby an Internal Ribosome Entry Site
Open accessAbstract
The human proto-oncogene c-myc encodes two proteins, c-Myc1 and c-Myc2, from two initiation codons, CUG and AUG, respectively. It is also transcribed from four alternative promoters (P0, P1, P2, and P3), giving rise to different RNA 5'-leader sequences, the long sizes of which suggest that they must be inefficiently translated by the classical ribosome scanning mechanism. Here we have examined the influence of three c-myc mRNA 5'-leaders on the translation of chimeric myc-CAT mRNAs. We observed that in the reticulocyte rabbit lysate, these 5'-leaders lead to cap-independent translation initiation. To determine whether this kind of initiation resulted from the presence of an internal ribosome entry site (IRES), COS-7 cells were transfected with bicistronic vectors containing the different c-myc 5'-leaders in the intercistronic region. An IRES was identified, requiring elements located within the P2 leader, between nucleotides -363 and -94 upstream from the CUG start codon. This is the first demonstration of the existence of IRES-dependent translation for a proto-oncogene. This IRES could be a translation enhancer, allowing activation of c-myc expression under the control of trans-acting factors and in response to specific cell stimuli.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hann, S. R., King, M. W., Bentley, D. L., Anderson, C. W., & Eisenman, R. N. (1988) · Cell · doi:10.1016/0092-8674(88)90507-7 · Cited by 474
Cited by
eIF4 Initiation Factors: Effectors of mRNA Recruitment to Ribosomes and Regulators of Translation
Gingras, A.-C., Raught, B., & Sonenberg, N. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.913 · Cited by 2,121
Translational control in stress and apoptosis
Holcik, M., & Sonenberg, N. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1618 · Cited by 1,366
Internal ribosome entry sites in eukaryotic mRNA molecules
Hellen, C. U. T., & Sarnow, P. (2001) · Genes & Development · doi:10.1101/gad.891101 · Cited by 986
SVITKIN, Y. V., PAUSE, A., HAGHIGHAT, A., PYRONNET, S., WITHERELL, G., BELSHAM, G. J., & SONENBERG, N. (2001) · RNA · doi:10.1017/s135583820100108x · Cited by 477
New frontiers in translational control of the cancer genome
Truitt, M. L., & Ruggero, D. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.27 · Cited by 378
The role of the 5′ untranslated region of an mRNA in translation regulation during development
van der Velden, A. W., & Thomas, A. A. M. (1999) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(98)00134-4 · Cited by 381
Lekven, A. C., Thorpe, C. J., Waxman, J. S., & Moon, R. T. (2001) · Developmental Cell · doi:10.1016/s1534-5807(01)00007-7 · Cited by 349
A Cell Cycle–Dependent Internal Ribosome Entry Site
Pyronnet, S., Pradayrol, L., & Sonenberg, N. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80240-3 · Cited by 325
Identification and Characterization of a Novel Cell Cycle–Regulated Internal Ribosome Entry Site
Cornelis, S., Bruynooghe, Y., Denecker, G., Van Huffel, S., Tinton, S., & Beyaert, R. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80239-7 · Cited by 325
Translational Control of Viral Gene Expression in Eukaryotes
Gale, M., Tan, S.-L., & Katze, M. G. (2000) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.64.2.239-280.2000 · Cited by 314
Erratum: New frontiers in translational control of the cancer genome
Truitt, M. L., & Ruggero, D. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.30 · Cited by 303
Huez, I., Créancier, L., Audigier, S., Gensac, M.-C., Prats, A.-C., & Prats, H. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.11.6178 · Cited by 297
Self-citationStrategies to Inhibit Myc and Their Clinical Applicability
Whitfield, J. R., Beaulieu, M.-E., & Soucek, L. (2017) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2017.00010 · Cited by 294
Re‐programming of translation following cell stress allows IRES‐mediated translation to predominate
Spriggs, K. A., Stoneley, M., Bushell, M., & Willis, A. E. (2008) · Biology of the Cell · doi:10.1042/bc20070098 · Cited by 294
Determinants of Rapamycin Sensitivity in Breast Cancer Cells
Noh, W.-C., Mondesire, W. H., Peng, J., Jian, W., Zhang, H., Dong, J., Mills, G. B., Hung, M.-C., & Meric-Bernstam, F. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0043 · Cited by 285
The major mRNA-associated protein YB-1 is a potent 5' cap-dependent mRNA stabilizer
Evdokimova, V. (2001) · The EMBO Journal · doi:10.1093/emboj/20.19.5491 · Cited by 279
JOHANNES, G., & SARNOW, P. (1998) · RNA · doi:10.1017/s1355838298981080 · Cited by 264
Generation of protein isoform diversity by alternative initiation of translation at non‐AUG codons
Touriol, C., Bornes, S., Bonnal, S., Audigier, S., Prats, H., Prats, A., & Vagner, S. (2003) · Biology of the Cell · doi:10.1016/s0248-4900(03)00033-9 · Cited by 257
Self-citationGueydan, C., Droogmans, L., Chalon, P., Huez, G., Caput, D., & Kruys, V. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.4.2322 · Cited by 254
Self-citationIRES Trans-Acting Factors, Key Actors of the Stress Response
Godet, A.-C., David, F., Hantelys, F., Tatin, F., Lacazette, E., Garmy-Susini, B., & Prats, A.-C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20040924 · Cited by 202
Self-citationDifferential translation and fragile X syndrome
Vanderklish, P. W., & Edelman, G. M. (2005) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2005.00134.x · Cited by 59
Wu, S., & Wagner, G. (2021) · Cell Systems · doi:10.1016/j.cels.2021.07.002 · Cited by 20
Metadata
- Authors
- Nanbru, C., Lafon, I., Audigier, S., Gensac, M.-C., Vagner, S., Huez, G., & Prats, A.-C.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1997-12
- Volume
- 272
- Issue
- 51
- Pages
- 32061-32066
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2028548180
- Cited by
- 243
- References
- 1
- FWCI
- 5.29
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.